These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Species specificity of the anticoagulant activity of human urinary soluble thrombomodulin. Takahashi Y, Hosaka Y, Imada K, Adachi T, Niina H, Mochizuki H. Thromb Res; 1998 Feb 15; 89(4):187-97. PubMed ID: 9651146 [Abstract] [Full Text] [Related]
6. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats. Gonda Y, Hirata S, Saitoh K, Aoki Y, Mohri M, Gomi K, Sugihara T, Kiyota T, Yamamoto S, Ishida T. Thromb Res; 1993 Aug 15; 71(4):325-35. PubMed ID: 8236161 [Abstract] [Full Text] [Related]
10. Effect of human urinary thrombomodulin on endotoxin-induced intravascular coagulation and pulmonary vascular injury in rats. Uchiba M, Okajima K, Murakami K, Johno M, Okabe H, Takatsuki K. Am J Hematol; 1997 Feb 15; 54(2):118-23. PubMed ID: 9034285 [Abstract] [Full Text] [Related]
12. The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation. Nawa K, Itani T, Ono M, Sakano K, Marumoto Y, Iwamoto M. Thromb Haemost; 1992 Mar 02; 67(3):366-70. PubMed ID: 1322570 [Abstract] [Full Text] [Related]
13. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma. Elisen MG, von dem Borne PA, Bouma BN, Meijers JC. Blood; 1998 Mar 01; 91(5):1542-7. PubMed ID: 9473218 [Abstract] [Full Text] [Related]
19. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III. Koyama T, Parkinson JF, Sié P, Bang NU, Müller-Berghaus G, Preissner KT. Eur J Biochem; 1991 Jun 15; 198(3):563-70. PubMed ID: 1646716 [Abstract] [Full Text] [Related]